Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marta Pérez-González
Observed names:
Marta Perez-Gonzalez,
Marta Pérez,
Marta Pérez González,
Perez-Gonzalez Marta,
Pérez, Marta
Institutions:
Navarre Institute of Health Research,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
Observed institutions:
WuXi AppTec (China),
Tianjin Economic-Technological Development Area,
Navarre Institute of Health Research,
Centro de Investigación Médica Aplicada,
UCL Queen Square Institute of Neurology,
University College London,
Universidad de Navarra
show all 7
ORCID:
0000-0002-1693-3361
Observed ORCID:
0000-0002-1693-3361
OpenAlex ID:
A5032165866
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
2016
·
Mar Cuadrado-Tejedor
, Carolina Garcia-Barroso
, et al.
·
Neuropsychopharmacology
·
108
PDF
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
2016
·
Obdulia Rabal
, Juan A. Sánchez-Arias
, et al.
·
Journal of Medicinal Chemistry
·
94
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
2018
·
Obdulia Rabal
, Juan A. Sánchez-Arias
, et al.
·
European Journal of Medicinal Chemistry
·
73
Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
2019
·
Obdulia Rabal
, Juan A. Sánchez-Arias
, et al.
·
ACS Chemical Neuroscience
·
50
PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment
2020
·
Marta Pérez-González
, Maite Mendioroz
, et al.
·
Progress in Neurobiology
·
49
PDF
Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
2019
·
Mar Cuadrado-Tejedor
, Marta Pérez-González
, et al.
·
Frontiers in Aging Neuroscience
·
47
PDF
Discovery of in Vivo Chemical Probes for Treating Alzheimer’s Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors
2018
·
Obdulia Rabal
, Juan A. Sánchez-Arias
, et al.
·
ACS Chemical Neuroscience
·
38
Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer’s Disease
2016
·
Juan A. Sánchez-Arias
, Obdulia Rabal
, et al.
·
ACS Chemical Neuroscience
·
37
Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease
2021
·
Marta Pérez-González
, Sara Badesso
, et al.
·
International Journal of Molecular Sciences
·
24
PDF
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice
2018
·
Aritz Lasarte-Cia
, Teresa Lozano
, et al.
·
Frontiers in Immunology
·
22
Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
2021
·
Mar Cuadrado-Tejedor
, Marta Pérez-González
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Cognitive impairments in a Down syndrome model with abnormal hippocampal and prefrontal dynamics and cytoarchitecture
2023
·
Phillip M. Muza
, Daniel Bush
, et al.
·
iScience
·
7
PDF
Affordable optical clearing and immunolabelling in mouse brain slices
2023
·
Phillip M. Muza
, Marta Pérez
, et al.
·
BMC Research Notes
·
4
PDF
Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation
2024
·
Pishan Chang
, Marta Pérez-González
, et al.
·
The Neuroscientist
·
3
PDF
Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders
2023
·
Marta Pérez-González
, Maite Solas
, et al.
·
Frontiers in Cellular Neuroscience
·
3
PDF
Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice
2025
·
Sara Badesso
, Marta Perez-Gonzalez
, et al.
·
Life Science Alliance
·
2
PDF
Faculty Opinions recommendation of Ts66Yah, a mouse model of Down syndrome with improved construct and face validity.
2023
·
Elizabeth Fisher
, Marta Pérez González
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Postnatal immune activation causes social deficits in a mouse model of tuberous sclerosis: Role of microglia and clinical implications.
2021
·
Elizabeth Fisher
, Marta Pérez González
, et al.
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease.
2021
·
Elizabeth Fisher
, Marta Pérez González
, et al.
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome.
2021
·
Elizabeth Fisher
, Phillip Muza
, et al.
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
アルツハイマー病治療のための治療戦略を設計するためのヒストンデアセチラーゼおよびホスホジエステラーゼ阻害剤の選択性の利点【jst・京大機械翻訳】
2019
·
Cuadrado-Tejedor Mar
, Perez-Gonzalez Marta
, et al.
Show more works
View as search
Works count:
23
Citation count:
572
H-index:
11
I10-index:
11
Year
Topic
Type